Researchers have used advanced microscopy and computational modeling to show how herpesvirus infection affects host-cell nucleus structure.

A recent international research project has used advanced microscopy techniques and computational modeling to discover why ...

Walter Dowdle, a renowned microbiologist, virologist, and public health leader who worked at the Centers for Disease Control and Prevention (CDC) and WHO, and made significant contributions to ...

Q: My blood pressure is a little high. My doctor is making me do constant at-home testing, take medication and check in with ...

Brandi Jones has over two decades of experience as a nurse in an acute care setting. Her clinical background includes pediatrics, medical-surgical, and women's health. She also specializes in ...

Gilead Sciences, Inc. (NASDAQ: GILD) and Assembly Biosciences, Inc. (NASDAQ: ASMB) announced on Monday that Gilead has exercised its combined option to exclusively license Assembly Bio’s herpes ...

Two years after Gilead Sciences secured the first option on Assembly Biosciences’ entire pipeline, the pharma has decided to pick the first fruits from the pact. Gilead is paying $35 million upfront ...

Researchers at Mass General Brigham have modified a herpes simplex virus (HSV-1) that stimulates the immune system to attack glioblastoma cells. A single dose of the modified virus increased T-cell, ...

Researchers at Mass General Brigham have modified a herpes simplex virus (HSV-1) that stimulates the immune system to attack glioblastoma cells. A single dose of the modified virus increased T-cell, ...

This is read by an automated voice. Please report any issues or inconsistencies here. Cancer-fighting, genetically engineered herpes simplex virus has been shown to be an effective treatment for ...

A class of antivirals called Pin1 inhibitors could reduce or stop outbreaks of herpes simplex virus 1 (HSV-1), the common infection behind oral herpes, according to new research published in Antiviral ...

In the mid-1990s, researchers identified the viral helicase–primase enzyme complex as a target for a potential anti-herpes simplex virus (HSV) therapy. Three decades later, the first promising ...